Some studies have demonstrated that DPSCs can induce regulatory T cells (Tregs) [41] via the PD- 1/PD-L1 pathway, contributing to immunosuppression and tolerance, which has potential therapeutic implications for autoimmune diseases like type 1 diabetes [5, 7]. Here, RPL17 is linked to autoimmune disease.